There was a ribbon, a crowd, the usual photo line-up of executives and officials. However, the more interesting detail from ...

The company has launched The Elysium Longevity Institute, a physician-led clinical program meant to bring rigor to a field ...

Twelve candidate aging rate indicators could offer faster route to testing geroprotective drugs – and to understanding what ...

AI model that reads heart scans becomes the first of its kind authorized by the FDA to catch heart attacks that standard ...

Inside the assumptions and interactive model behind our $617b longevity biotech TAM – and why you need not agree with us.

Yale-led analysis harmonized 51 studies under one standardized pipeline, and senolytics came out looking shaky.

Durham University spinout Magnitude Biosciences raises $1.3 million to scale a platform that screens drugs in living worms, ...

Company bets that AI-assisted analysis and a leaner trial design can get PrimeC to patients years sooner than the usual ...

Cara Cassino spent a year advising Oligomerix from the boardroom. Now she’s running the company as its lead drug enters human ...

PhytoGaia spotlights new clinical data on ingredients for healthy aging, liver support and, notably, pet wellness. Walk the ...

After reconsidering, Canada’s Drug Agency issued a final recommendation supporting public reimbursement of lecanemab, sold as ...

Tulu Health has launched in the US, betting that AI built for patient relationships can plug the churn draining membership clinics.